204 related articles for article (PubMed ID: 20596476)
1. Folate Functionalized Boron Nitride Nanotubes and their Selective Uptake by Glioblastoma Multiforme Cells: Implications for their Use as Boron Carriers in Clinical Boron Neutron Capture Therapy.
Ciofani G; Raffa V; Menciassi A; Cuschieri A
Nanoscale Res Lett; 2008 Nov; 4(2):113-121. PubMed ID: 20596476
[TBL] [Abstract][Full Text] [Related]
2. Boron neutron capture therapy for glioblastoma multiforme.
van Rij CM; Wilhelm AJ; Sauerwein WA; van Loenen AC
Pharm World Sci; 2005 Apr; 27(2):92-5. PubMed ID: 15999918
[TBL] [Abstract][Full Text] [Related]
3. Boron neutron capture therapy of cancer: current status and future prospects.
Barth RF; Coderre JA; Vicente MG; Blue TE
Clin Cancer Res; 2005 Jun; 11(11):3987-4002. PubMed ID: 15930333
[TBL] [Abstract][Full Text] [Related]
4. Boron neutron capture therapy of brain tumors: past history, current status, and future potential.
Barth RF; Soloway AH; Brugger RM
Cancer Invest; 1996; 14(6):534-50. PubMed ID: 8951358
[TBL] [Abstract][Full Text] [Related]
5. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
[TBL] [Abstract][Full Text] [Related]
6. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice.
Zavjalov E; Zaboronok A; Kanygin V; Kasatova A; Kichigin A; Mukhamadiyarov R; Razumov I; Sycheva T; Mathis BJ; Maezono SEB; Matsumura A; Taskaev S
Int J Radiat Biol; 2020 Jul; 96(7):868-878. PubMed ID: 32339057
[No Abstract] [Full Text] [Related]
7. Self-assembling A6K peptide nanotubes as a mercaptoundecahydrododecaborate (BSH) delivery system for boron neutron capture therapy (BNCT).
Michiue H; Kitamatsu M; Fukunaga A; Tsuboi N; Fujimura A; Matsushita H; Igawa K; Kasai T; Kondo N; Matsui H; Furuya S
J Control Release; 2021 Feb; 330():788-796. PubMed ID: 33188824
[TBL] [Abstract][Full Text] [Related]
8. Boron Neutron Capture Therapy: Current Status and Challenges.
Wang S; Zhang Z; Miao L; Li Y
Front Oncol; 2022; 12():788770. PubMed ID: 35433432
[TBL] [Abstract][Full Text] [Related]
9. Boron neutron capture therapy for glioblastoma.
Yamamoto T; Nakai K; Matsumura A
Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
[TBL] [Abstract][Full Text] [Related]
10. Boron neutron capture therapy for malignant gliomas.
Diaz AZ; Coderre JA; Chanana AD; Ma R
Ann Med; 2000 Feb; 32(1):81-5. PubMed ID: 10711581
[TBL] [Abstract][Full Text] [Related]
11. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of boron nitride nanotubes in combination with thermal neutron irradiation on BNCT.
Nakamura H; Koganei H; Miyoshi T; Sakurai Y; Ono K; Suzuki M
Bioorg Med Chem Lett; 2015 Jan; 25(2):172-4. PubMed ID: 25522821
[TBL] [Abstract][Full Text] [Related]
13. Boron Neutron Capture Therapy: A Review of Clinical Applications.
Malouff TD; Seneviratne DS; Ebner DK; Stross WC; Waddle MR; Trifiletti DM; Krishnan S
Front Oncol; 2021; 11():601820. PubMed ID: 33718149
[TBL] [Abstract][Full Text] [Related]
14. Tumor Cell-Specific 2'-Fluoro RNA Aptamer Conjugated with
Vorobyeva MA; Dymova MA; Novopashina DS; Kuligina EV; Timoshenko VV; Kolesnikov IA; Taskaev SY; Richter VA; Venyaminova AG
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298946
[TBL] [Abstract][Full Text] [Related]
15. The rationale and requirements for the development of boron neutron capture therapy of brain tumors.
Soloway AH; Barth RF; Gahbauer RA; Blue TE; Goodman JH
J Neurooncol; 1997 May; 33(1-2):9-18. PubMed ID: 9151219
[TBL] [Abstract][Full Text] [Related]
16. Clinical phase-I study of Na2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT).
Haritz D; Gabel D; Huiskamp R
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1175-81. PubMed ID: 8175403
[TBL] [Abstract][Full Text] [Related]
17. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
[TBL] [Abstract][Full Text] [Related]
18. Boron neutron capture therapy: cellular targeting of high linear energy transfer radiation.
Coderre JA; Turcotte JC; Riley KJ; Binns PJ; Harling OK; Kiger WS
Technol Cancer Res Treat; 2003 Oct; 2(5):355-75. PubMed ID: 14529302
[TBL] [Abstract][Full Text] [Related]
19. [Neutron capture therapy in the treatment of glioblastoma multiforme. Initial experience in the Czech Republic].
Honová H; Safanda M; Petruzelka L; Burian J; Marek M; Rejchrt J; Sus F; Tovarys F; Dbalý V; Honzátko J; Tomandl I; Mares V
Cas Lek Cesk; 2004; 143(1):44-7. PubMed ID: 15061119
[TBL] [Abstract][Full Text] [Related]
20. A Model for Estimating Dose-Rate Effects on Cell-Killing of Human Melanoma after Boron Neutron Capture Therapy.
Matsuya Y; Fukunaga H; Omura M; Date H
Cells; 2020 Apr; 9(5):. PubMed ID: 32365916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
